Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nat Commun ; 11(1): 3105, 2020 06 19.
Artigo em Inglês | MEDLINE | ID: mdl-32561723

RESUMO

Genetic perturbations that affect bacterial resistance to antibiotics have been characterized genome-wide, but how do such perturbations interact with subsequent evolutionary adaptation to the drug? Here, we show that strong epistasis between resistance mutations and systematically identified genes can be exploited to control spontaneous resistance evolution. We evolved hundreds of Escherichia coli K-12 mutant populations in parallel, using a robotic platform that tightly controls population size and selection pressure. We find a global diminishing-returns epistasis pattern: strains that are initially more sensitive generally undergo larger resistance gains. However, some gene deletion strains deviate from this general trend and curtail the evolvability of resistance, including deletions of genes for membrane transport, LPS biosynthesis, and chaperones. Deletions of efflux pump genes force evolution on inferior mutational paths, not explored in the wild type, and some of these essentially block resistance evolution. This effect is due to strong negative epistasis with resistance mutations. The identified genes and cellular functions provide potential targets for development of adjuvants that may block spontaneous resistance evolution when combined with antibiotics.


Assuntos
Antibacterianos/farmacologia , Evolução Molecular Direcionada/métodos , Resistência Microbiana a Medicamentos/genética , Epistasia Genética , Escherichia coli K12/genética , Escherichia coli K12/efeitos dos fármacos , Deleção de Genes , Genes Bacterianos/genética , Seleção Genética/efeitos dos fármacos
2.
PLoS Comput Biol ; 13(7): e1005609, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28719607

RESUMO

Mutator strains are expected to evolve when the availability and effect of beneficial mutations are high enough to counteract the disadvantage from deleterious mutations that will inevitably accumulate. As the population becomes more adapted to its environment, both availability and effect of beneficial mutations necessarily decrease and mutation rates are predicted to decrease. It has been shown that certain molecular mechanisms can lead to increased mutation rates when the organism finds itself in a stressful environment. While this may be a correlated response to other functions, it could also be an adaptive mechanism, raising mutation rates only when it is most advantageous. Here, we use a mathematical model to investigate the plausibility of the adaptive hypothesis. We show that such a mechanism can be mantained if the population is subjected to diverse stresses. By simulating various antibiotic treatment schemes, we find that combination treatments can reduce the effectiveness of second-order selection on stress-induced mutagenesis. We discuss the implications of our results to strategies of antibiotic therapy.


Assuntos
Modelos Genéticos , Mutagênese/genética , Mutação/genética , Estresse Fisiológico/genética , Alelos , Biologia Computacional , Evolução Molecular
3.
Curr Opin Biotechnol ; 46: 90-97, 2017 08.
Artigo em Inglês | MEDLINE | ID: mdl-28292709

RESUMO

The rising prevalence of antibiotic resistant bacteria is an increasingly serious public health challenge. To address this problem, recent work ranging from clinical studies to theoretical modeling has provided valuable insights into the mechanisms of resistance, its emergence and spread, and ways to counteract it. A deeper understanding of the underlying dynamics of resistance evolution will require a combination of experimental and theoretical expertise from different disciplines and new technology for studying evolution in the laboratory. Here, we review recent advances in the quantitative understanding of the mechanisms and evolution of antibiotic resistance. We focus on key theoretical concepts and new technology that enables well-controlled experiments. We further highlight key challenges that can be met in the near future to ultimately develop effective strategies for combating resistance.


Assuntos
Evolução Molecular Direcionada , Resistência Microbiana a Medicamentos , Bactérias/genética , Fenômenos Fisiológicos Celulares , Resistência Microbiana a Medicamentos/genética , Epistasia Genética , Humanos , Mutação/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA